Orexin receptor antagonist DAYVIGO TM has been approved for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults. The medication was tested in 2,000 patients before being approved by the FDA. Clinical trials are much more than just a drug, patient and a placebo, which is why Yourway offers ancillary material sourcing, including medical equipment and devices as well as diagnostic and testing equipment.